Secondary Stroke Prevention in People With Schizophrenia by Moira K. Kapral, Joan Porter, Paul Kurdyak, Amy Y. X. Yu, Emilie Matheson, Jiming Fang, Leanne K. Casaubon, Eshita Kapoor, Kathleen A. Sheehan

Subjects: Get full text

Third phase of cardiac rehabilitation: a nurse-based “home-control” model by Sara Albertini, Antonella Ciocca, Cristina Opasich, Gian Domenico Pinna, Franco Cobelli

Subjects: Get full text

Cardiac Prevention and Rehabilitation “3.0”: From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)... by Roberto F.E. Pedretti, Francesco Fattirolli, Raffaele Griffo, Marco Ambrosetti, Elisabetta Angelino, Silvia Brazzo, Ugo Corrà, Nicolò Dasseni, Pompilio Faggiano, Giuseppe Favretto, Oreste Febo, Marina Ferrari, Francesco Giallauria, Cesare Greco, Manuela Iannucci, Maria Teresa La Rovere, Mario Mallardo, Antonio Mazza, Massimo Piepoli, Carmine Riccio, Simonetta Scalvini, Luigi Tavazzi, Pier Luigi Temporelli, Gian Francesco Mureddu

Subjects: Get full text

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended? by George Galyfos, Argyri Sianou

Subjects: Get full text

Stroke secondary prevention, a non-surgical and non-pharmacological consensus definition: results of a Delphi study by Maggie Lawrence, Eric Asaba, Elaine Duncan, Marie Elf, Gunilla Eriksson, James Faulkner, Susanne Guidetti, Birgitta Johansson, Christina Kruuse, Danielle Lambrick, Caitlin Longman, Lena von Koch, Xu Wang, Olive Lennon

Subjects: Get full text

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues by N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan

Subjects: Get full text

Magnetic Resonance Imaging Assists With Determining Etiology After Transient Ischemic Attack or Minor Stroke by Margaret Moores, Raed A. Joundi, Nishita Singh, Andrew M. Penn, Kristine Votova, Eric E. Smith, Shelagh B. Coutts

Subjects: Get full text

A Step Forward Toward Controlling Leptospirosis: Comprehensive and Collective Efforts by Megha Mehta, Prakash B Patel, N B Patel, Vaibhav Gharat, R K Bansal

Subjects: Get full text

Secondary prevention effectiveness in patients with stable angina by Rasim Kutlu, T. M. Murataliev

Subjects: Get full text

Statins in Secondary Prevention of Atrial Fibrillation by V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin

Subjects: Get full text

Comanagement of Risk Factors in Patients With Coronary Artery Disease: Insights From the APPEAR Study by Vittal Hejjaji, Kensey Gosch, Philip G. Jones, Tracie Breeding, John A. Spertus, Suzanne V. Arnold

Subjects: Get full text

WHF Roadmap on Secondary Prevention of CVD by David A. Wood

Subjects: Get full text

International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post‐MI Patients: A Collaborative Analysis of the Chronic Kidney... by Yejin Mok, Shoshana H. Ballew, Lori D. Bash, Deepak L. Bhatt, William E. Boden, Marc P. Bonaca, Juan Jesus Carrero, Josef Coresh, Ralph B. D'Agostino, C. Raina Elley, F. Gerry R. Fowkes, Sun Ha Jee, Csaba P. Kovesdy, Kenneth W. Mahaffey, Girish Nadkarni, Eric D. Peterson, Yingying Sang, Kunihiro Matsushita

Subjects: Get full text

Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease by Danh Q. Nguyen, Neil Keshvani, Alvin Chandra, Pamela L. Alebna, Dave L. Dixon, Michael D. Shapiro, Erin D. Michos, Laurence S. Sperling, Ambarish Pandey, Anurag Mehta

Subjects: “…Secondary prevention…”
Get full text

A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease by Aparna Sajja, MD, Hsin-Fang Li, Kateri J. Spinelli, Amir Ali, Salim S. Virani, Seth S. Martin, Ty J. Gluckman

Subjects: Get full text

FREQUENCY OF OCCURRENCE OF RISK FACTORS AND ADHERENCE TO DRUG THERAPY IN YAKUTS WHO UNDERWENT Q-POSITIVE MYOCARDIAL INFARCTION by E. S. Kylbanova, E. V. Guryeva, A. V. Pavlova

Subjects: “…secondary prevention…”
Get full text

Long‐Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage by Juan Pablo Castello, Kay‐Cheong Teo, Jessica R. Abramson, Sophia Keins, Courtney E. Takahashi, Ian Y. H. Leung, William C. Y. Leung, Yujie Wang, Christina Kourkoulis, Evangelos Pavlos Myserlis, Andrew D. Warren, Jonathan Henry, Koon‐Ho Chan, Raymond T. F. Cheung, Shu‐Leong Ho, M. Edip Gurol, Anand Viswanathan, Steven M. Greenberg, Christopher D. Anderson, Kui‐Kai Lau, Jonathan Rosand, Alessandro Biffi

Subjects: Get full text

Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Ac... by Baris Gencer, Konstantinos C. Koskinas, Lorenz Räber, Alexios Karagiannis, David Nanchen, Reto Auer, David Carballo, Sebastian Carballo, Roland Klingenberg, Dik Heg, Christian M. Matter, Thomas F. Lüscher, Nicolas Rodondi, François Mach, Stephan Windecker

Subjects: Get full text

Inappropriate ICD Shock as a Result of TASER Discharge by Chirag R. Barbhaiya, MD, Craig Moskowitz, MD, Harish Duraiswami, CCDS, Lior Jankelson, MD, PhD, Robert J. Knotts, MD, Scott Bernstein, MD, David Park, MD, PhD, Douglas Holmes, MD, Anthony Aizer, MD, MS, Larry A. Chinitz, MD

Subjects: Get full text

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials by Marit de Jong, H. Bart van der Worp, Yolanda van der Graaf, Frank L. J. Visseren, Jan Westerink

Subjects: Get full text